SKYE BIOSCIENCE INC - KAITLYN ARSENAULT TO STEP DOWN AS CFO EFFECTIVE FEB 20, 2026 - SEC FILING
Source text: [ID:n0001628280-26-010186]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.